Table 1.
Global incidence, mortality and DALYs of genitourinary cancers from 1990 to 2019
| Kidney cancer | Bladder cancer | Prostate cancer | |||||
|---|---|---|---|---|---|---|---|
| Both | Male | Female | Both | Male | Female | Male | |
| 1990* | |||||||
| Incident cases (× 103) |
145.91 (140.80–150.33) |
86.06 (82.70–89.44) |
59.85 (57.39–62.13) |
234.75 (225.46–243.08) |
177.76 (170.77–184.13) |
56.99 (53.45–60.31) |
524.11 (409.13–613.01) |
| Deaths (× 103) |
72.10 (68.88–74.67) |
43.46 (41.33–45.51) |
28.64 (27.24–29.66) |
121.50 (114.75–127.17) |
88.12 (83.47–91.86) |
33.38 (30.66–35.84) |
233.00 (191.40–268.88) |
| DALYs (× 103) |
2039.40 (1943.70–2144.10) |
1260.71 (1189.84–1349.99) |
778.69 (738.21–829.72) |
2567.06 (2429.47–2691.11) |
1901.45 (1798.60–1987.27) |
665.60 (613.69–722.30) |
4360.51 (3528.03–4951.01) |
| ASIR (1/105) |
3.53 (3.40–3.63) |
4.51 (4.34–4.67) |
2.70 (2.59–2.80) |
6.27 (5.98–6.50) |
10.94 (10.43–11.34) |
2.77 (2.59–2.93) |
34.13 (26.83–39.65) |
| ASMR (1/105) |
1.86 (1.77–1.93) |
2.50 (2.37–2.60) |
1.36 (1.28–1.41) |
3.49 (3.27–3.66) |
6.13 (5.77–6.41) |
1.70 (1.54–1.82) |
18.13 (14.68–21.19) |
| ASDR (1/105) |
47.28 (45.22–49.37) |
61.96 (58.81–65.46) |
34.30 (32.65–36.08) |
66.59 (63.00–69.73) |
111.68 (105.56–116.61) |
31.66 (29.19–34.29) |
286.30 (232.78–326.21) |
| 2019* | |||||||
| Incident cases (× 103) |
371.75 (344.59–402.35) |
240.54 (220.79–261.82) |
131.21 (119.71–142.42) |
524.30 (475.95–569.43) |
407.87 (371.30–443.75) |
116.44 (103.71–128.21) |
1410.45 (1227.90–1825.77) |
| Deaths (× 103) |
166.44 (155.46–176.3) |
108.77 (101.48–115.82) |
57.67 (52.24–61.90) |
228.73 (210.74–243.19) |
169.21 (156.92–180.66) |
59.53 (52.33–64.58) |
486.84 (420.5–593.69) |
| DALYs (× 103) |
4052.82 (3801.04–4317.49) |
2735.71 (2544.82–2931.33) |
1317.11 (1228.35–1413.53) |
4392.58 (4090.44–4702.73) |
3326.50 (3093.91–3570.17) |
1066.08 (962.71–1150.12) |
8644.87 (7548.02–10,559.87) |
| ASIR (1/105) |
4.55 (4.22–4.93) |
6.24 (5.74–6.79) |
3.07 (2.80–3.33) |
6.52 (5.93–7.09) |
11.28 (10.23–12.27) |
2.66 (2.37–2.93) |
38.63 (33.63–49.83) |
| ASMR (1/105) |
2.08 (1.93–2.20) |
2.99 (2.78–3.18) |
1.33 (1.20–1.42) |
2.94 (2.70–3.13) |
5.09 (4.69–5.44) |
1.36 (1.19–1.47) |
15.28 (13.00–18.57) |
| ASDR (1/105) |
49.62 (46.46–52.94) |
70.06 (65.14–75.07) |
31.08 (28.95–33.38) |
54.20 (50.35–57.97) |
90.17 (83.63–96.61) |
24.43 (22.10–26.35) |
244.07 (211.78–297.72) |
| 1990–2019 | |||||||
| ASIR | |||||||
| EAPC (95% CI) |
0.87 (0.76–0.99) |
1.13 (1.01–1.26) |
0.39 (0.30–0.49) |
0.07 (0.04–0.10) |
0.06 (0.03–0.08) |
− 0.24 (− 0.29 to − 0.18) |
0.26 (0.15–0.37) |
| ASMR | |||||||
| EAPC (95% CI) |
0.35 (0.26–0.45) |
0.61 (0.51–0.70) |
− 0.13 (− 0.20 to − 0.05) |
− 0.68 (− 0.71 to − 0.65) |
− 0.71 (− 0.73 to − 0.68) |
− 0.89 (− 0.94 to − 0.84) |
− 0.75 (− 0.84 to − 0.67) |
| ASDR | |||||||
| EAPC (95% CI) |
0.12 (0.04–0.20) |
0.40 (0.30–0.49) |
− 0.41 (− 0.46 to − 0.36) |
− 0.83 (− 0.86 to − 0.79) |
− 0.84 (− 0.87 to − 0.81) |
− 1.04 (− 1.08 to − 0.99) |
− 0.71 (− 0.78 to − 0.64) |
DALYs disability-adjusted life-years, ASIR age-standardized incidence rate, ASMR age-standardized mortality rate, ASDR age-standardized DALYs rate; EAPC estimated annual percentage change, CI confidence interval
*All data reported as number or rate (95% uncertainty interval)